Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Serum hepatitis B virus DNA level as a risk predictor for liver disease complications

Nature Clinical Practice Gastroenterology & Hepatology volume 3, pages 426–427 (2006)Cite this article

boxed-textChen CJ et al. (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65–73

Periodic quantification of serum hepatitis B virus DNA levels should be considered in patients with chronic hepatitis B virus infection; levels >10,000 copies/ml indicate increased risk for disease progression and hepatocellular carcinoma

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. EASL Jury (2003) EASL International Consensus Conference on Hepatitis B: 13–14 September, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol 38: 533–540

  2. Brechot C (2004) Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127 (Suppl 1): S56–S61

    Article  CAS  Google Scholar 

  3. Iloeje UH et al. (2006) Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 130: 678–686

    Article  Google Scholar 

  4. Hadziyannis SJ et al. (2005) Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. N Engl J Med 352: 2673–2681

    Article  CAS  Google Scholar 

  5. Lai CL et al. (2006) Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 354: 1011–1020

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. practicing clinician and research group leader,

    Frank Tacke & Christian Trautwein

  2. Head and Chairman of the Medical Clinic III at the University Hospital Aachen, Aachen, Germany

    Frank Tacke & Christian Trautwein

Authors
  1. Frank Tacke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christian Trautwein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Trautwein.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tacke, F., Trautwein, C. Serum hepatitis B virus DNA level as a risk predictor for liver disease complications. Nat Rev Gastroenterol Hepatol 3, 426–427 (2006). https://doi.org/10.1038/ncpgasthep0561

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0561

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing